• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受肺叶切除术的原发性肺癌患者术后短期预后因素:一项关于术后早期复发预后预测因素的研究

Postoperative short-term prognostic factors in patients with primary lung cancer who undergo lobectomy: a study on the prognostic predictors of early postoperative recurrence.

作者信息

Noda Yuki, Matsudaira Hideki, Kato Daiki, Shibazaki Takamasa, Mori Shohei, Nakada Takeo, Yabe Mitsuo, Hirano Jun, Hoya Yoshiyuki, Ohtsuka Takashi

机构信息

Department of Surgery, Machida Municipal Hospital, Tokyo, Japan.

Division of Thoracic Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.

出版信息

J Thorac Dis. 2024 Nov 30;16(11):7490-7498. doi: 10.21037/jtd-24-987. Epub 2024 Nov 29.

DOI:10.21037/jtd-24-987
PMID:39678899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11635254/
Abstract

BACKGROUND

Lung cancer is among the most common types of cancers worldwide, and surgery can be a curative treatment option for this condition. However, some patients experience postoperative recurrence. Hence, predicting early postoperative recurrence to improve patient prognosis is important. This study aimed to determine the usefulness of nutritional inflammation indexes in predicting the prognosis of early recurrence after lung cancer surgery.

METHODS

A retrospective cohort study was conducted on 310 patients with primary lung cancer who underwent lung lobectomy at Jikei University Hospital from January 1, 2013, to December 31, 2017. The prognostic nutrition index (PNI), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and modified Glasgow prognostic score (mGPS) were calculated. The patients were classified into the high and low groups based on the receiver operating characteristic (ROC) curves. Furthermore, the association between these indexes and postoperative recurrence was analyzed via univariate analysis and using the Kaplan-Meier method.

RESULTS

The mean age of the patients was 67.0 years, and the male-to-female ratio was 199:111. The mean observation period was 30.6 months. Patients with a low NLR and mGPS had a significantly longer 5-year recurrence-free survival than those with a high NLR and mGPS (P=0.045 and 0.02, respectively). Patients with a low PNI had a significantly higher 1-year recurrence rate than those with a high PNI (P=0.007).

CONCLUSIONS

The PNI is associated with 1-year recurrence, and NLR and mGPS are considerably associated with 5-year postoperative recurrence in patients with lung cancer. Hence, these nutritional inflammatory indices can be useful in predicting postoperative recurrence.

摘要

背景

肺癌是全球最常见的癌症类型之一,手术是治疗这种疾病的一种治愈性选择。然而,一些患者会出现术后复发。因此,预测术后早期复发以改善患者预后很重要。本研究旨在确定营养炎症指标在预测肺癌手术后早期复发预后中的作用。

方法

对2013年1月1日至2017年12月31日在慈惠会医科大学医院接受肺叶切除术的310例原发性肺癌患者进行了一项回顾性队列研究。计算了预后营养指数(PNI)、中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)和改良格拉斯哥预后评分(mGPS)。根据受试者工作特征(ROC)曲线将患者分为高分组和低分组。此外,通过单因素分析和使用Kaplan-Meier方法分析了这些指标与术后复发之间的关联。

结果

患者的平均年龄为67.0岁,男女比例为199:111。平均观察期为30.6个月。NLR和mGPS低水平的患者5年无复发生存期明显长于NLR和mGPS高水平的患者(分别为P=0.045和0.02)。PNI低水平的患者1年复发率明显高于PNI高水平的患者(P=0.007)。

结论

PNI与1年复发相关,NLR和mGPS与肺癌患者术后5年复发密切相关。因此,这些营养炎症指标可用于预测术后复发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/955d/11635254/9a89b7e60329/jtd-16-11-7490-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/955d/11635254/91a46fba9809/jtd-16-11-7490-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/955d/11635254/f3f422a1ff3d/jtd-16-11-7490-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/955d/11635254/9a89b7e60329/jtd-16-11-7490-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/955d/11635254/91a46fba9809/jtd-16-11-7490-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/955d/11635254/f3f422a1ff3d/jtd-16-11-7490-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/955d/11635254/9a89b7e60329/jtd-16-11-7490-f3.jpg

相似文献

1
Postoperative short-term prognostic factors in patients with primary lung cancer who undergo lobectomy: a study on the prognostic predictors of early postoperative recurrence.接受肺叶切除术的原发性肺癌患者术后短期预后因素:一项关于术后早期复发预后预测因素的研究
J Thorac Dis. 2024 Nov 30;16(11):7490-7498. doi: 10.21037/jtd-24-987. Epub 2024 Nov 29.
2
Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer.改良格拉斯哥预后评分、预后营养指数和 ECOG 体能状态评分比肌肉减少症、恶病质和一些炎症指标更能预测转移性胃癌的生存。
Nutr Cancer. 2021;73(2):230-238. doi: 10.1080/01635581.2020.1749290. Epub 2020 Apr 9.
3
Comparison of systemic inflammatory and nutritional scores in colorectal cancer patients who underwent potentially curative resection.接受根治性切除的结直肠癌患者全身炎症和营养评分的比较。
Int J Clin Oncol. 2017 Aug;22(4):740-748. doi: 10.1007/s10147-017-1102-5. Epub 2017 Feb 17.
4
Prognostic Value of Inflammation and Nutrition-Based Scores in Non-Small Cell Lung Cancer.炎症和营养评分在非小细胞肺癌中的预后价值
Med Princ Pract. 2024;33(2):122-132. doi: 10.1159/000535781. Epub 2023 Dec 13.
5
The prognostic significance of inflammation-based scores in patients with ampullary carcinoma after pancreaticoduodenectomy.基于炎症的评分系统对胰十二指肠切除术后壶腹癌患者预后的意义。
BMC Cancer. 2020 Oct 10;20(1):981. doi: 10.1186/s12885-020-07482-0.
6
The Relationship Between Preoperative Systemic Immune Inflammation Index and Prognostic Nutritional Index and the Prognosis of Patients With Alveolar Hydatid Disease.术前全身免疫炎症指数与预后营养指数与泡型包虫病患者预后的关系。
Front Immunol. 2021 Jun 24;12:691364. doi: 10.3389/fimmu.2021.691364. eCollection 2021.
7
The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.预后营养指数(PNI)和中性粒细胞与淋巴细胞比值(NLR)对铂类化疗治疗晚期非小细胞肺癌的预后价值。
Ann Palliat Med. 2020 May;9(3):967-978. doi: 10.21037/apm.2020.04.31. Epub 2020 Apr 21.
8
Comparison of Prognostic Values of Seven Immune Indexes in Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab: How Effective Can They Be Regarding Our Treatment Decisions?比较纳武利尤单抗治疗晚期非小细胞肺癌的七种免疫指标的预后价值:它们对我们的治疗决策有多大效果?
Medicina (Kaunas). 2024 Nov 1;60(11):1792. doi: 10.3390/medicina60111792.
9
Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.炎症评分可预测接受经动脉化疗栓塞术和重组人5型腺病毒H101治疗的肝细胞癌患者的生存情况。
PLoS One. 2017 Mar 29;12(3):e0174769. doi: 10.1371/journal.pone.0174769. eCollection 2017.
10
Prognostic impact of the high-sensitivity modified Glasgow prognostic score in patients with resectable non-small cell lung cancer.高敏改良格拉斯哥预后评分对可切除非小细胞肺癌患者的预后影响
J Cancer Res Ther. 2016 Apr-Jun;12(2):945-51. doi: 10.4103/0973-1482.176168.

引用本文的文献

1
The association of the advanced lung cancer inflammation index with postoperative complications in patients undergoing lung resection for bronchiectasis.晚期肺癌炎症指数与因支气管扩张症接受肺切除手术患者术后并发症的相关性
J Thorac Dis. 2025 Jun 30;17(6):3577-3589. doi: 10.21037/jtd-2024-2271. Epub 2025 Jun 6.

本文引用的文献

1
Pre-Operative Measures of Systemic Inflammation Predict Survival After Surgery for Primary Lung Cancer.系统性炎症的术前测量可预测原发性肺癌手术后的生存率。
Clin Lung Cancer. 2024 Jul;25(5):460-467.e7. doi: 10.1016/j.cllc.2024.04.018. Epub 2024 May 8.
2
Neoadjuvant therapy in non-small cell lung cancer.非小细胞肺癌的新辅助治疗
Crit Rev Oncol Hematol. 2023 Oct;190:104080. doi: 10.1016/j.critrevonc.2023.104080. Epub 2023 Aug 1.
3
Systemic Inflammation and Lung Cancer: Is It a Real Paradigm? Prognostic Value of Inflammatory Indexes in Patients with Resected Non-Small-Cell Lung Cancer.
全身炎症与肺癌:这是一种真实的范例吗?炎症指标对非小细胞肺癌切除患者的预后价值。
Cancers (Basel). 2023 Mar 20;15(6):1854. doi: 10.3390/cancers15061854.
4
Prognostic value of preoperative modified Glasgow prognostic score in surgical non-small cell lung cancer: A meta-analysis.术前改良格拉斯哥预后评分在手术治疗非小细胞肺癌中的预后价值:一项荟萃分析。
Front Surg. 2023 Jan 9;9:1094973. doi: 10.3389/fsurg.2022.1094973. eCollection 2022.
5
Assessing the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Stage I Non-Small-Cell Lung Cancer with Complete Resection.评估完全切除的 I 期非小细胞肺癌中性粒细胞与淋巴细胞比值的预后价值。
Can Respir J. 2022 Jun 22;2022:6837872. doi: 10.1155/2022/6837872. eCollection 2022.
6
The MLR, NLR, PLR and D-dimer are associated with clinical outcome in lung cancer patients treated with surgery.MLR、NLR、PLR 和 D-二聚体与接受手术治疗的肺癌患者的临床结局相关。
BMC Pulm Med. 2022 Mar 25;22(1):104. doi: 10.1186/s12890-022-01901-7.
7
Prognostic Value of Glasgow Prognostic Score in Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis.格拉斯哥预后评分在非小细胞肺癌中的预后价值:系统评价和荟萃分析。
Pathol Oncol Res. 2022 Feb 15;28:1610109. doi: 10.3389/pore.2022.1610109. eCollection 2022.
8
Postoperative prognostic nutritional index as a prognostic factor after non-small cell lung cancer surgery.术后预后营养指数作为非小细胞肺癌手术后的预后因素。
Gen Thorac Cardiovasc Surg. 2020 Oct;68(10):1163-1171. doi: 10.1007/s11748-020-01366-7. Epub 2020 Apr 23.
9
Impact of Age on Inflammation-Based Scores among Patients Diagnosed with Stage III Non-Small Cell Lung Cancer.年龄对 III 期非小细胞肺癌患者炎症相关评分的影响。
Oncology. 2020;98(8):528-533. doi: 10.1159/000506204. Epub 2020 Mar 23.
10
Complete Blood Cell Count-Derived Inflammatory Biomarkers in Early-Stage Non-Small-Cell Lung Cancer.全血细胞计数衍生的炎症生物标志物在早期非小细胞肺癌中的研究
Ann Thorac Cardiovasc Surg. 2020 Oct 21;26(5):248-255. doi: 10.5761/atcs.oa.19-00315. Epub 2020 Feb 19.